Targeting deubiquitinases for cancer therapy
Abstract The ubiquitin‐proteasome system assumes a critical role in numerous cellular processes, and among its components, deubiquitinases (DUBs) have emerged as essential regulators. With roughly 100 DUBs encoded within the human genome, these enzymes can be categorized into two main types: cystein...
Main Authors: | Qian Xue, Daolin Tang, Xin Chen, Jinbao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.242 |
Similar Items
-
Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle
by: Jessica Proulx, et al.
Published: (2021-04-01) -
Proteasomal Degradation Machinery: Favorite Target of HIV-1 Proteins
by: Sneh Lata, et al.
Published: (2018-11-01) -
On the Study of Deubiquitinases: Using the Right Tools for the Job
by: Cody Caba, et al.
Published: (2022-05-01) -
A cryptic K48 ubiquitin chain binding site on UCH37 is required for its role in proteasomal degradation
by: Jiale Du, et al.
Published: (2022-04-01) -
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
by: Martin Kastnes, et al.
Published: (2023-05-01)